Rob Labriola

Rob Labriola is an accomplished executive with extensive experience in regulatory operations within the biotechnology and pharmaceutical industries. Currently serving as Executive Director at Garuda Therapeutics since March 2023, Rob previously held key leadership roles at Certara Synchrogenix, where duties included Executive Director and Senior Director of Regulatory Operations from June 2015 to February 2023. Other notable positions include Senior Director at Flexion Therapeutics, Director of Global Regulatory Operations at Alexion Pharmaceuticals, and various leadership roles at Sunovion Pharmaceuticals, Millennium Pharmaceuticals, and Janssen Pharmaceutica. Rob also contributed to academia as a Faculty/Senior Fellow at the National Defense University and has a background in business systems analysis from Unisys.